Global Contraceptive Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
The Global Contraceptive Market is expected to grow from USD 32,567.26 Million in 2018 to USD 105,998.56 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 18.36%.
The positioning of the Global Contraceptive Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Contraceptive Market including are Allergan Plc, Bayer Corporation, Church & Dwight Co., Inc., CooperSurgical, Inc., Mayer Laboratories, Inc., Agile Therapeutics, Ani Pharmaceuticals Inc., Fuji Latex Co. Ltd, Gilead Sciences Inc., Johnson & Johnson, Merck & Co. Inc., Pfizer Inc, Reckitt Benckiser Group Plc, Teva Pharmaceuticals Industries Ltd., and Veru Inc..
On the basis of Drugs, the Global Contraceptive Market is studied across Contraceptive Injectable, Emergency Contraceptive Pills, Oral Contraceptives, and Transdermal Patches.
On the basis of Gender, the Global Contraceptive Market is studied across Female Contraceptive Devices and Male Contraceptive Devices.
On the basis of Distribution, the Global Contraceptive Market is studied across Clinics, Hospital Pharmacy, Independent Pharmacy, and Online Platform.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Contraceptive Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Contraceptive Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Contraceptive Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Contraceptive Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Contraceptive Market
The report answers questions such as:
1. What is the market size of Contraceptive market in the Global?
2. What are the factors that affect the growth in the Global Contraceptive Market over the forecast period?
3. What is the competitive position in the Global Contraceptive Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Contraceptive Market?
5. What are the opportunities in the Global Contraceptive Market?
6. What are the modes of entering the Global Contraceptive Market?
The positioning of the Global Contraceptive Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Contraceptive Market including are Allergan Plc, Bayer Corporation, Church & Dwight Co., Inc., CooperSurgical, Inc., Mayer Laboratories, Inc., Agile Therapeutics, Ani Pharmaceuticals Inc., Fuji Latex Co. Ltd, Gilead Sciences Inc., Johnson & Johnson, Merck & Co. Inc., Pfizer Inc, Reckitt Benckiser Group Plc, Teva Pharmaceuticals Industries Ltd., and Veru Inc..
On the basis of Drugs, the Global Contraceptive Market is studied across Contraceptive Injectable, Emergency Contraceptive Pills, Oral Contraceptives, and Transdermal Patches.
On the basis of Gender, the Global Contraceptive Market is studied across Female Contraceptive Devices and Male Contraceptive Devices.
On the basis of Distribution, the Global Contraceptive Market is studied across Clinics, Hospital Pharmacy, Independent Pharmacy, and Online Platform.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Contraceptive Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Contraceptive Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Contraceptive Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Contraceptive Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Contraceptive Market
The report answers questions such as:
1. What is the market size of Contraceptive market in the Global?
2. What are the factors that affect the growth in the Global Contraceptive Market over the forecast period?
3. What is the competitive position in the Global Contraceptive Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Contraceptive Market?
5. What are the opportunities in the Global Contraceptive Market?
6. What are the modes of entering the Global Contraceptive Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Contraceptive Market
3.2. Opportunities in the Contraceptive Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Growing incidence of unwanted pregnancies and sexually transmitted diseases
4.2.1.2. Rising government initiatives to promote awareness regarding unintended pregnancies and increasing population
4.2.1.3. Popularity of oral contraceptive pills in women of reproductive age
4.2.1.4. Easy of availability of various contraceptives, such as of contraceptive pills and condoms
4.2.2. Restraints
4.2.2.1. Side effects of oral contraceptive drugs
4.2.3. Opportunities
4.2.3.1. Government and non-government organizations supporting programs to encourage contraception in emerging economies
4.2.3.2. Growth opportunities for affordable contraceptives method such as Sino-Implants and novel contraceptive
4.2.4. Challenges
4.2.4.1. Lack of information and misconceptions about different contraceptives
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. GLOBAL CONTRACEPTIVE MARKET, BY DRUGS
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Contraceptive Injectable
5.4. Emergency Contraceptive Pills
5.5. Oral Contraceptives
5.6. Transdermal Patches
6. GLOBAL CONTRACEPTIVE MARKET, BY GENDER
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Female Contraceptive Devices
6.4. Male Contraceptive Devices
7. GLOBAL CONTRACEPTIVE MARKET, BY DISTRIBUTION
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Clinics
7.4. Hospital Pharmacy
7.5. Independent Pharmacy
7.6. Online Platform
8. GLOBAL CONTRACEPTIVE MARKET, BY GEOGRAPHY
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Americas
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
8.3.3. Argentina
8.3.4. Brazil
8.3.5. Canada
8.3.6. Mexico
8.3.7. United States
8.4. Asia-Pacific
8.4.1. Overview
8.4.2. Market Sizing & Forecasting
8.4.3. Australia
8.4.4. China
8.4.5. India
8.4.6. Japan
8.5. Europe, Middle East & Africa
8.5.1. Overview
8.5.2. Market Sizing & Forecasting
8.5.3. France
8.5.4. Germany
8.5.5. Italy
8.5.6. Spain
8.5.7. United Kingdom
9. COMPETITIVE LANDSCAPE
9.1. 360iResearch FPNV Positioning Matrix for Global Contraceptive Market
9.2. Market Vendor Ranking Analysis for Global Contraceptive Market
9.3. Competitive News Feed Analysis for Global Contraceptive Market
10. COMPANY USABILITY PROFILES
10.1. Allergan Plc
10.1.1. Overview
10.1.2. Strategy
10.1.3. SWOT
10.2. Bayer Corporation
10.2.1. Overview
10.2.2. Strategy
10.2.3. SWOT
10.3. Church & Dwight Co., Inc.
10.3.1. Overview
10.3.2. Strategy
10.3.3. SWOT
10.4. CooperSurgical, Inc.
10.4.1. Overview
10.4.2. Strategy
10.4.3. SWOT
10.5. Mayer Laboratories, Inc.
10.5.1. Overview
10.5.2. Strategy
10.5.3. SWOT
10.6. Agile Therapeutics
10.7. Ani Pharmaceuticals Inc.
10.8. Fuji Latex Co. Ltd
10.9. Gilead Sciences Inc.
10.10. Johnson & Johnson
10.11. Merck & Co. Inc.
10.12. Pfizer Inc
10.13. Reckitt Benckiser Group Plc
10.14. Teva Pharmaceuticals Industries Ltd.
10.15. Veru Inc.
11. APPENDIX
11.1. Discussion Guide
11.2. Top Reports
11.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.3. Author Details
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Contraceptive Market
3.2. Opportunities in the Contraceptive Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Growing incidence of unwanted pregnancies and sexually transmitted diseases
4.2.1.2. Rising government initiatives to promote awareness regarding unintended pregnancies and increasing population
4.2.1.3. Popularity of oral contraceptive pills in women of reproductive age
4.2.1.4. Easy of availability of various contraceptives, such as of contraceptive pills and condoms
4.2.2. Restraints
4.2.2.1. Side effects of oral contraceptive drugs
4.2.3. Opportunities
4.2.3.1. Government and non-government organizations supporting programs to encourage contraception in emerging economies
4.2.3.2. Growth opportunities for affordable contraceptives method such as Sino-Implants and novel contraceptive
4.2.4. Challenges
4.2.4.1. Lack of information and misconceptions about different contraceptives
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. GLOBAL CONTRACEPTIVE MARKET, BY DRUGS
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Contraceptive Injectable
5.4. Emergency Contraceptive Pills
5.5. Oral Contraceptives
5.6. Transdermal Patches
6. GLOBAL CONTRACEPTIVE MARKET, BY GENDER
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Female Contraceptive Devices
6.4. Male Contraceptive Devices
7. GLOBAL CONTRACEPTIVE MARKET, BY DISTRIBUTION
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Clinics
7.4. Hospital Pharmacy
7.5. Independent Pharmacy
7.6. Online Platform
8. GLOBAL CONTRACEPTIVE MARKET, BY GEOGRAPHY
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Americas
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
8.3.3. Argentina
8.3.4. Brazil
8.3.5. Canada
8.3.6. Mexico
8.3.7. United States
8.4. Asia-Pacific
8.4.1. Overview
8.4.2. Market Sizing & Forecasting
8.4.3. Australia
8.4.4. China
8.4.5. India
8.4.6. Japan
8.5. Europe, Middle East & Africa
8.5.1. Overview
8.5.2. Market Sizing & Forecasting
8.5.3. France
8.5.4. Germany
8.5.5. Italy
8.5.6. Spain
8.5.7. United Kingdom
9. COMPETITIVE LANDSCAPE
9.1. 360iResearch FPNV Positioning Matrix for Global Contraceptive Market
9.2. Market Vendor Ranking Analysis for Global Contraceptive Market
9.3. Competitive News Feed Analysis for Global Contraceptive Market
10. COMPANY USABILITY PROFILES
10.1. Allergan Plc
10.1.1. Overview
10.1.2. Strategy
10.1.3. SWOT
10.2. Bayer Corporation
10.2.1. Overview
10.2.2. Strategy
10.2.3. SWOT
10.3. Church & Dwight Co., Inc.
10.3.1. Overview
10.3.2. Strategy
10.3.3. SWOT
10.4. CooperSurgical, Inc.
10.4.1. Overview
10.4.2. Strategy
10.4.3. SWOT
10.5. Mayer Laboratories, Inc.
10.5.1. Overview
10.5.2. Strategy
10.5.3. SWOT
10.6. Agile Therapeutics
10.7. Ani Pharmaceuticals Inc.
10.8. Fuji Latex Co. Ltd
10.9. Gilead Sciences Inc.
10.10. Johnson & Johnson
10.11. Merck & Co. Inc.
10.12. Pfizer Inc
10.13. Reckitt Benckiser Group Plc
10.14. Teva Pharmaceuticals Industries Ltd.
10.15. Veru Inc.
11. APPENDIX
11.1. Discussion Guide
11.2. Top Reports
11.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.3. Author Details
